FRINK Linked Data Fragments server

Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C2693> ?p ?o ?g. }

• NCIT_C2693 IAO_0000115 "The hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation." @default.
• NCIT_C2693 NCIT_A32 NCIT_C1909 @default.
• NCIT_C2693 NCIT_A6 NCIT_C65530 @default.
• NCIT_C2693 NCIT_A7 NCIT_C17068 @default.
• NCIT_C2693 NCIT_NHC0 "C2693" @default.
• NCIT_C2693 NCIT_P106 "Organic Chemical" @default.
• NCIT_C2693 NCIT_P106 "Pharmacologic Substance" @default.
• NCIT_C2693 NCIT_P107 "Erlotinib Hydrochloride" @default.
• NCIT_C2693 NCIT_P108 "Erlotinib Hydrochloride" @default.
• NCIT_C2693 NCIT_P175 "718781" @default.
• NCIT_C2693 NCIT_P207 "C1533491" @default.
• NCIT_C2693 NCIT_P210 "183319-69-9" @default.
• NCIT_C2693 NCIT_P302 "Malignant glioma; Locally advanced or metastic non-small cell lung carcinoma; Locally advanced, unresectable or metastatic pancreatic carcinoma" @default.
• NCIT_C2693 NCIT_P319 "DA87705X9K" @default.
• NCIT_C2693 NCIT_P322 "CTRP" @default.
• NCIT_C2693 NCIT_P322 "FDA" @default.
• NCIT_C2693 NCIT_P322 "GDC" @default.
• NCIT_C2693 NCIT_P325 "A drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Erlotinib hydrochloride is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor." @default.
• NCIT_C2693 NCIT_P329 "38428" @default.
• NCIT_C2693 NCIT_P330 "38428" @default.
• NCIT_C2693 NCIT_P350 "C22H23N3O4.HCl" @default.
• NCIT_C2693 NCIT_P366 "Erlotinib" @default.
• NCIT_C2693 NCIT_P368 "CHEBI:53509" @default.
• NCIT_C2693 NCIT_P375 "Erlotinib Hydrochloride" @default.
• NCIT_C2693 NCIT_P399 "38428" @default.
• NCIT_C2693 NCIT_R124 NCIT_C17828 @default.
• NCIT_C2693 NCIT_R124 NCIT_C18992 @default.
• NCIT_C2693 NCIT_R124 NCIT_C19143 @default.
• NCIT_C2693 NCIT_R124 NCIT_C21124 @default.
• NCIT_C2693 NCIT_R124 NCIT_C40702 @default.
• NCIT_C2693 NCIT_R124 NCIT_C40703 @default.
• NCIT_C2693 NCIT_R124 NCIT_C40704 @default.
• NCIT_C2693 NCIT_R125 NCIT_C17133 @default.
• NCIT_C2693 NCIT_R125 NCIT_C17710 @default.
• NCIT_C2693 NCIT_R125 NCIT_C17828 @default.
• NCIT_C2693 NCIT_R125 NCIT_C18081 @default.
• NCIT_C2693 NCIT_R125 NCIT_C20480 @default.
• NCIT_C2693 NCIT_R125 NCIT_C20751 @default.
• NCIT_C2693 NCIT_R125 NCIT_C28498 @default.
• NCIT_C2693 NCIT_R125 NCIT_C40576 @default.
• NCIT_C2693 NCIT_R125 NCIT_C40577 @default.
• NCIT_C2693 NCIT_R125 NCIT_C40821 @default.
• NCIT_C2693 NCIT_R146 NCIT_C105526 @default.
• NCIT_C2693 NCIT_R146 NCIT_C16554 @default.
• NCIT_C2693 NCIT_R146 NCIT_C16984 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17018 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17020 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17021 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17068 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17210 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17660 @default.
• NCIT_C2693 NCIT_R146 NCIT_C17728 @default.
• NCIT_C2693 NCIT_R146 NCIT_C18106 @default.
• NCIT_C2693 NCIT_R146 NCIT_C18506 @default.
• NCIT_C2693 NCIT_R146 NCIT_C20027 @default.
• NCIT_C2693 NCIT_R146 NCIT_C26548 @default.
• NCIT_C2693 normalizedInformationContent "81.252167948509552" @default.
• NCIT_C2693 referenceCount "17" @default.
• NCIT_C2693 hasExactSynonym "CP-358" @default.
• NCIT_C2693 hasExactSynonym "CP-358,774" @default.
• NCIT_C2693 hasExactSynonym "Cp-358,774" @default.
• NCIT_C2693 hasExactSynonym "ERLOTINIB HYDROCHLORIDE" @default.
• NCIT_C2693 hasExactSynonym "Erlotinib Hydrochloride" @default.
• NCIT_C2693 hasExactSynonym "N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride" @default.
• NCIT_C2693 hasExactSynonym "OSI-774" @default.
• NCIT_C2693 hasExactSynonym "Tarceva" @default.
• NCIT_C2693 hasExactSynonym "erlotinib hydrochloride" @default.
• NCIT_C2693 inSubset NCIT_C116977 @default.
• NCIT_C2693 inSubset NCIT_C116978 @default.
• NCIT_C2693 inSubset NCIT_C128784 @default.
• NCIT_C2693 inSubset NCIT_C157711 @default.
• NCIT_C2693 inSubset NCIT_C157712 @default.
• NCIT_C2693 inSubset NCIT_C176424 @default.
• NCIT_C2693 inSubset NCIT_C177537 @default.
• NCIT_C2693 inSubset NCIT_C63923 @default.
• NCIT_C2693 type Class @default.
• NCIT_C2693 isDefinedBy ncit.owl @default.
• NCIT_C2693 label "Erlotinib Hydrochloride" @default.
• NCIT_C2693 subClassOf B1b8eaf5887c57e02781b9c68510da174 @default.
• NCIT_C2693 subClassOf B2c72b48eaf9e2bd2f03bb2918a728885 @default.
• NCIT_C2693 subClassOf B3019aab4e40cbdb29089f241c4017263 @default.
• NCIT_C2693 subClassOf B7cc6168a1065cf6e7cf0738a0da7fbc8 @default.
• NCIT_C2693 subClassOf B7cdf89ef7eb9192ca0dcf7bf071743d2 @default.
• NCIT_C2693 subClassOf B8a4db9b24ce79260f14ec56de4db79ae @default.
• NCIT_C2693 subClassOf B8b2ebd34526b5b255fc173dc8d016148 @default.
• NCIT_C2693 subClassOf Bc31e8cd78ccd2ed064d4090ccea959e4 @default.
• NCIT_C2693 subClassOf Bc90d38165b7a85f2486bb4ecd9aba3ed @default.
• NCIT_C2693 subClassOf Bd672fb27595014a6188572819c66a782 @default.
• NCIT_C2693 subClassOf NCIT_C129824 @default.
• NCIT_C2693 subClassOf NCIT_C129825 @default.
• NCIT_C2693 subClassOf NCIT_C1404 @default.
• NCIT_C2693 subClassOf NCIT_C163758 @default.
• NCIT_C2693 subClassOf NCIT_C163952 @default.
• NCIT_C2693 subClassOf NCIT_C1908 @default.
• NCIT_C2693 subClassOf NCIT_C1909 @default.
• NCIT_C2693 subClassOf NCIT_C1967 @default.
• NCIT_C2693 subClassOf NCIT_C2167 @default.
• NCIT_C2693 subClassOf NCIT_C2189 @default.
• NCIT_C2693 subClassOf NCIT_C2693 @default.
• NCIT_C2693 subClassOf NCIT_C274 @default.

• next